Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
FLGT on Nasdaq
Shares outstanding
31,312,500
Price per share
$27.53
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
17,798,431
Total reported value
$467,530,174
% of total 13F portfolios
0%
Share change
+899,589
Value change
+$24,299,566
Number of holders
178
Price from insider filings
$27.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BARCLAYS PLC 7.6% +43% $42,396,117 +$12,335,507 2,338,451 +41% Barclays PLC 31 Mar 2025
BlackRock, Inc. 5.9% $32,993,391 1,819,823 BlackRock, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 3% -43% $24,677,381 -$19,766,494 939,375 -44% Millennium Management LLC 31 Dec 2025

As of 31 Dec 2025, 178 institutional investors reported holding 17,798,431 shares of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT). This represents 57% of the company’s total 31,312,500 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) together control 46% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.5% 2,962,234 -0.44% 0% $77,817,877
VANGUARD GROUP INC 4% 1,260,014 +6.8% 0% $33,100,568
ACADIAN ASSET MANAGEMENT LLC 3.8% 1,185,890 +4% 0.05% $31,137,000
MILLENNIUM MANAGEMENT LLC 3% 939,375 -36% 0.02% $24,677,381
DIMENSIONAL FUND ADVISORS LP 2.8% 889,012 -22% 0% $23,354,860
RTW INVESTMENTS, LP 2.3% 705,027 0.19% $18,521,059
D. E. Shaw & Co., Inc. 2.2% 701,305 +24% 0.01% $18,423,282
GEODE CAPITAL MANAGEMENT, LLC 1.6% 508,224 +1.3% 0% $13,353,401
AMERIPRISE FINANCIAL INC 1.6% 499,511 +0.92% 0% $13,122,155
STATE STREET CORP 1.6% 493,664 -1.7% 0% $12,968,553
DEUTSCHE BANK AG\ 1.4% 438,996 -13% 0% $11,532,425
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 402,802 +12% 0% $10,581,609
Connor, Clark & Lunn Investment Management Ltd. 1.2% 374,825 +13% 0.03% $9,846,653
GOLDMAN SACHS GROUP INC 1.1% 348,533 +89% 0% $9,155,962
Nuveen, LLC 1.1% 331,643 +14% 0% $8,712,261
MORGAN STANLEY 1% 315,252 +14% 0% $8,281,670
TWO SIGMA INVESTMENTS, LP 0.95% 297,355 +89% 0.01% $7,811,516
Qube Research & Technologies Ltd 0.92% 286,511 +237% 0.01% $7,526,644
JPMORGAN CHASE & CO 0.8% 250,128 -16% 0% $6,570,862
CITADEL ADVISORS LLC 0.78% 243,124 -35% 0% $6,386,868
Point72 Asset Management, L.P. 0.76% 236,954 -36% 0.01% $6,224,782
Diametric Capital, LP 0.64% 200,160 -17% 1.4% $5,258,203
TWO SIGMA ADVISERS, LP 0.62% 193,500 +124% 0.01% $5,083,245
NORTHERN TRUST CORP 0.57% 178,825 -11% 0% $4,697,733
BARCLAYS PLC 0.55% 172,286 -3.7% 0% $4,525,952

Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 17,798,431 $467,530,174 +$24,299,566 $26.27 178
2025 Q3 17,228,150 $389,319,933 +$21,532,521 $22.60 163
2025 Q2 16,260,263 $323,227,753 +$1,152,439 $19.88 165
2025 Q1 16,317,307 $275,768,406 -$14,217,098 $16.90 173
2024 Q4 17,016,195 $314,285,279 +$12,985,883 $18.47 185
2024 Q3 16,092,056 $349,642,907 +$18,556,959 $21.73 181
2024 Q2 15,271,785 $299,655,107 +$9,367,412 $19.62 170
2024 Q1 14,727,786 $319,564,135 +$6,539,138 $21.70 177
2023 Q4 14,302,809 $413,495,913 +$4,547,542 $28.91 193
2023 Q3 14,229,204 $380,479,266 +$6,537,668 $26.74 196
2023 Q2 13,900,018 $514,629,091 +$13,570,378 $37.03 210
2023 Q1 13,537,003 $422,618,519 +$14,324,645 $31.22 213
2022 Q4 13,130,080 $391,069,830 -$9,588,373 $29.78 218
2022 Q3 13,298,290 $506,859,271 -$7,820,533 $38.12 217
2022 Q2 12,997,411 $708,963,224 +$53,955,153 $54.53 247
2022 Q1 12,047,292 $751,600,750 +$40,161,746 $62.41 263
2021 Q4 11,205,792 $1,127,293,672 -$26,292,784 $100.59 284
2021 Q3 11,367,430 $1,022,253,660 +$64,809,061 $89.95 258
2021 Q2 10,632,791 $980,578,944 +$54,311,867 $92.23 246
2021 Q1 10,008,047 $966,031,706 +$64,885,192 $96.62 243
2020 Q4 9,615,937 $501,565,082 +$82,198,208 $52.10 184
2020 Q3 8,084,326 $323,850,761 +$79,786,110 $40.04 122
2020 Q2 6,322,946 $101,163,272 +$14,541,369 $16.00 81
2020 Q1 6,111,180 $65,545,855 +$3,544,598 $10.76 72
2019 Q4 5,668,534 $73,105,675 +$35,387,759 $12.90 70
2019 Q3 2,927,084 $30,408,049 +$16,888,791 $10.39 33
2019 Q2 1,301,144 $8,691,007 +$411,415 $6.68 12
2019 Q1 1,242,460 $7,393,006 +$220,569 $5.95 15
2018 Q4 1,210,059 $3,835,003 -$982,557 $3.17 13
2018 Q3 1,458,250 $5,731,004 +$22,470 $3.93 15
2018 Q2 1,452,436 $6,013,004 +$11,608 $4.14 15
2018 Q1 1,449,767 $5,789,004 +$112,502 $3.99 18
2017 Q4 1,415,208 $6,199,004 -$6,549,628 $4.38 16
2017 Q3 2,390,312 $11,378,005 -$4,107,706 $4.79 19
2017 Q2 2,976,441 $19,019,006 -$5,819,346 $6.39 20
2017 Q1 3,492,074 $38,134,153 +$4,840,117 $10.92 35
2016 Q4 3,066,506 $35,477,491 +$5,733,496 $11.57 36
2016 Q3 2,647,726 $24,413,000 +$24,413,000 $9.22 16